Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- B of A Securities raised the price target for CMS Energy Corp (NYSE:CMS) from $82 to $88. B of A Securities analyst Ross Fowler maintained a Buy rating. CMS Energy shares closed at $77.04 on Monday. See how other analysts view this stock.
- Goldman Sachs raised Ramaco Resources Inc (NASDAQ:METC) price target from $14 to $15. Goldman Sachs analyst Brian Lee upgraded the stock from Sell to Neutral. Ramaco Resources shares closed at $14.07 on Monday. See how other analysts view this stock.
- Truist Securities slashed price target for Packaging Corp Of America (NYSE:PKG) from $267 to $260. Truist Securities analyst Michael Roxland maintained a Buy rating. Packaging Corp shares closed at $213.41 on Monday. See how other analysts view this stock.
- Baird slashed the price target for Mohawk Industries Inc (NYSE:MHK) from $156 to $118. Baird analyst Timothy Wojs downgraded the stock from Outperform to Neutral. Mohawk Industries shares closed at $109.51 on Monday. See how other analysts view this stock.
- Needham raised Crocs Inc (NASDAQ:CROX) price target from $118 to $132. Needham analyst Tom Nikic maintained a Buy rating. Crocs shares closed at $111.19 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. raised Century Therapeutics Inc (NASDAQ:IPSC) price target from $2 to $5. HC Wainwright & Co. analyst Mitchell S. Kapoor maintained a Buy rating. Century Therapeutics shares closed at $2.34 on Monday. See how other analysts view this stock.
- Keefe, Bruyette & Woods raised SmartFinancial Inc (NYSE:SMBK) price target from $42 to $46. Keefe, Bruyette & Woods analyst Catherine Mealor maintained a Market Perform rating. SmartFinancial shares closed at $42.76 on Monday. See how other analysts view this stock.
- Morgan Stanley raised the price target for Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) from $78 to $100. Morgan Stanley analyst Michael Ulz upgraded the stock from Equal-Weight to Overweight. Arrowhead Pharmaceuticals shares closed at $69.25 on Monday. See how other analysts view this stock.
- B of A Securities cut Leidos Holdings Inc (NYSE:LDOS) price target from $235 to $200. B of A Securities analyst Mariana Perez maintained a Buy rating. Leidos shares closed at $154.82 on Monday. See how other analysts view this stock.
- B of A Securities raised Antero Resources Corp (NYSE:AR) price target from $39 to $44. B of A Securities analyst Kalei Akamine maintained a Buy rating. Antero Resources shares closed at $36.57 on Monday. See how other analysts view this stock.
Considering buying ARWR stock? Here’s what analysts think:

Photo via Shutterstock
Login to comment